$SKAS
Saker Aviation Services, Inc.

2020 Q4 Form 10-K Financial Statement

#000143774921007824 Filed on March 31, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 2019 Q4
Revenue $673.1K $3.506M $2.949M
YoY Change -77.17% -69.69% 2.32%
Cost Of Revenue $478.4K $2.525M $1.452M
YoY Change -67.06% -56.84% -1.59%
Gross Profit $194.7K $980.9K $1.497M
YoY Change -86.99% -82.84% 6.42%
Gross Profit Margin 28.92% 27.98% 50.75%
Selling, General & Admin $596.0K $2.472M $1.268M
YoY Change -53.0% -47.05% 5.91%
% of Gross Profit 306.14% 252.03% 84.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.50K $119.0K $43.69K
YoY Change -53.08% -4.03% -32.18%
% of Gross Profit 10.53% 12.13% 2.92%
Operating Expenses $596.0K $2.472M $1.268M
YoY Change -53.0% -47.05% 5.91%
Operating Profit -$401.3K -$1.491M $228.4K
YoY Change -275.73% -242.36% 9.35%
Interest Expense -$4.170K $24.03K $4.320K
YoY Change -196.53% 200.8% -226.32%
% of Operating Profit 1.89%
Other Income/Expense, Net -$412.7K -$688.6K
YoY Change -3708.7%
Pretax Income -$818.2K -$2.180M $232.7K
YoY Change -451.63% -304.37% 13.02%
Income Tax $86.04K -$431.0K $121.5K
% Of Pretax Income 52.2%
Net Earnings -$904.2K -$1.749M $111.2K
YoY Change -912.86% -361.96% -0.09%
Net Earnings / Revenue -134.34% -49.88% 3.77%
Basic Earnings Per Share -$1.71
Diluted Earnings Per Share -$878.8K -$1.71 $109.3K
COMMON SHARES
Basic Shares Outstanding 1.025M 1.013M
Diluted Shares Outstanding 1.025M

Balance Sheet

Concept 2020 Q4 2020 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.899M $1.899M $3.597M
YoY Change -47.21% -47.21% 26.73%
Cash & Equivalents $1.899M $3.597M
Short-Term Investments
Other Short-Term Assets $257.6K $257.6K $564.6K
YoY Change -54.37% -54.37% -0.32%
Inventory $163.6K $163.6K $181.2K
Prepaid Expenses $257.6K $294.6K
Receivables $262.1K $262.1K $678.0K
Other Receivables $955.5K $955.5K $188.8K
Total Short-Term Assets $3.538M $3.538M $5.210M
YoY Change -32.1% -32.1% 11.0%
LONG-TERM ASSETS
Property, Plant & Equipment $258.9K $704.6K $323.3K
YoY Change -19.94% -13.94% -16.69%
Goodwill $750.0K $750.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.510K $2.510K $478.5K
YoY Change -99.48% -99.48% -6.08%
Total Long-Term Assets $1.457M $1.457M $2.047M
YoY Change -28.83% -28.83% 24.25%
TOTAL ASSETS
Total Short-Term Assets $3.538M $3.538M $5.210M
Total Long-Term Assets $1.457M $1.457M $2.047M
Total Assets $4.995M $4.995M $7.257M
YoY Change -31.17% -31.17% 14.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $62.02K $62.02K $397.3K
YoY Change -84.39% -84.39% 14.08%
Accrued Expenses $219.3K $262.6K $319.6K
YoY Change -31.37% -30.93% 10.72%
Deferred Revenue $80.88K $130.4K
YoY Change -37.97% 2.8%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $304.8K $304.8K $0.00
YoY Change
Total Short-Term Liabilities $710.3K $710.4K $1.281M
YoY Change -44.56% -44.56% 55.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $376.9K $376.9K $399.7K
YoY Change -5.7% -5.7%
Total Long-Term Liabilities $376.9K $376.9K $0.00
YoY Change -5.7% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $710.3K $710.4K $1.281M
Total Long-Term Liabilities $376.9K $376.9K $0.00
Total Liabilities $1.087M $1.087M $1.681M
YoY Change -35.32% -35.32% 68.97%
SHAREHOLDERS EQUITY
Retained Earnings -$16.03M -$14.27M
YoY Change 12.33% -1.16%
Common Stock $19.94M $19.85M
YoY Change 0.46% 0.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.908M $3.908M $5.576M
YoY Change
Total Liabilities & Shareholders Equity $4.995M $4.995M $7.257M
YoY Change -31.17% -31.17% 14.45%

Cashflow Statement

Concept 2020 Q4 2020 2019 Q4
OPERATING ACTIVITIES
Net Income -$904.2K -$1.749M $111.2K
YoY Change -912.86% -361.96% -0.09%
Depreciation, Depletion And Amortization $20.50K $119.0K $43.69K
YoY Change -53.08% -4.03% -32.18%
Cash From Operating Activities -$478.8K -$1.590M $241.6K
YoY Change -298.18% -241.52% 135.93%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $4.913K -$5.730K
YoY Change -100.0% -97.19% -45.43%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 -$4.913K -$5.730K
YoY Change -100.0% -94.38% -114.41%
FINANCING ACTIVITIES
Cash Dividend Paid $383.9K
YoY Change 203.17%
Common Stock Issuance & Retirement, Net $16.20K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.450K -$103.0K -139.9K
YoY Change -106.75% -62.88% 60.29%
NET CHANGE
Cash From Operating Activities -478.8K -$1.590M 241.6K
Cash From Investing Activities 0.000 -$4.913K -5.730K
Cash From Financing Activities 9.450K -$103.0K -139.9K
Net Change In Cash -469.4K -$1.698M 95.96K
YoY Change -589.15% -323.82% 74.89%
FREE CASH FLOW
Cash From Operating Activities -$478.8K -$1.590M $241.6K
Capital Expenditures $0.00 $4.913K -$5.730K
Free Cash Flow -$478.8K -$1.595M $247.4K
YoY Change -293.59% -268.06% 119.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 skas Additional Stock Issued During Period Value Reverse Stock Split
AdditionalStockIssuedDuringPeriodValueReverseStockSplit
0
CY2019 skas Adjustment To Additional Paid In Capital Issuance Of Additional Common Stock
AdjustmentToAdditionalPaidInCapitalIssuanceOfAdditionalCommonStock
-28202
CY2020 skas Adjustment To Additional Paid In Capital Issuance Of Additional Common Stock
AdjustmentToAdditionalPaidInCapitalIssuanceOfAdditionalCommonStock
16196
CY2019 skas Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
33997
CY2020 skas Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
74659
CY2020 skas Change In Accounts Receivable Through Issuance Of A Note Receivable
ChangeInAccountsReceivableThroughIssuanceOfANoteReceivable
CY2019 skas Change In Accounts Receivable Through Issuance Of A Note Receivable
ChangeInAccountsReceivableThroughIssuanceOfANoteReceivable
276036
CY2020 skas Change In Assets Held For Sale From Note Receivable
ChangeInAssetsHeldForSaleFromNoteReceivable
CY2020 skas Shares Based Compensation Stock Options Unamortized Fair Value
SharesBasedCompensationStockOptionsUnamortizedFairValue
34396
CY2020 skas Variable Expenses Gallon
VariableExpensesGallon
36000
CY2019 skas Variable Expenses Gallon
VariableExpensesGallon
52000
CY2020Q4 skas Working Capital
WorkingCapital
2827585
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
62021
CY2019 skas Change In Assets Held For Sale From Note Receivable
ChangeInAssetsHeldForSaleFromNoteReceivable
270000
CY2019Q4 skas Dividends Per Share To Be Paid In Equal Quarterly Installments
DividendsPerShareToBePaidInEqualQuarterlyInstallments
0.125
CY2020 skas Effective Income Tax Rate Reconciliation Operating Loss Carryback Net Percent
EffectiveIncomeTaxRateReconciliationOperatingLossCarrybackNetPercent
0.158
CY2019 skas Effective Income Tax Rate Reconciliation Operating Loss Carryback Net Percent
EffectiveIncomeTaxRateReconciliationOperatingLossCarrybackNetPercent
CY2015 skas Environmental Remediation Agreed Percentage Of Reduction In Tenant Operated Tourist Flights
EnvironmentalRemediationAgreedPercentageOfReductionInTenantOperatedTouristFlights
0.2
CY2015 skas Environmental Remediation Agreed Percentage Of Reduction In Tenant Operated Tourist Flights By Year One
EnvironmentalRemediationAgreedPercentageOfReductionInTenantOperatedTouristFlightsByYearOne
0.4
CY2015 skas Environmental Remediation Agreed Percentage Of Reduction In Tenant Operated Tourist Flights By Year Two
EnvironmentalRemediationAgreedPercentageOfReductionInTenantOperatedTouristFlightsByYearTwo
0.5
CY2019Q1 skas Financing Receivable Interest Rate
FinancingReceivableInterestRate
0.075
CY2020 skas Incremental Common Shares Attributable To Options And Warrants
IncrementalCommonSharesAttributableToOptionsAndWarrants
CY2019 skas Incremental Common Shares Attributable To Options And Warrants
IncrementalCommonSharesAttributableToOptionsAndWarrants
12886
CY2020 skas Sharebased Compensation Weighted Average Remaining Amortization Period
SharebasedCompensationWeightedAverageRemainingAmortizationPeriod
P5Y
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1028863
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3333334
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1028863
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1020135
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
678045
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
397343
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
262101
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
219307
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
319557
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3745861
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3676488
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19909230
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19818637
CY2020 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
158481
CY2019 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
456218
CY2020 us-gaap Advertising Expense
AdvertisingExpense
4000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
29840
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
53328
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40402
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
270000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
CY2020Q4 us-gaap Assets
Assets
4995010
CY2019Q4 us-gaap Assets
Assets
7257417
CY2020Q4 us-gaap Assets Current
AssetsCurrent
3537931
CY2019Q4 us-gaap Assets Current
AssetsCurrent
5210212
CY2020Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
CY2019Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
270000
CY2020Q4 us-gaap Cash
Cash
1899082
CY2019Q4 us-gaap Cash
Cash
3597491
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1899082
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3597491
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2838649
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1899082
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1698409
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
758842
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3333334
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1020135
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1006768
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
30866
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
30604
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
80878
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
130395
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2525341
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5851066
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-906960
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
368000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
476000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
476000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
31000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
3000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
526000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
518000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
476000
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
466000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
471000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
60000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
44000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
526000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
42000
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2512
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2512
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
119039
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
124264
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
119000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
124000
CY2019 us-gaap Dividends
Dividends
500000
CY2020 us-gaap Dividends
Dividends
10539
CY2020Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
CY2019Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
373370
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
373370
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.71
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.71
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.197
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.374
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.218
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.047
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.164
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
40169
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
38891
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
205000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
205000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
144000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2200000
CY2020Q4 us-gaap Goodwill
Goodwill
750000
CY2019Q4 us-gaap Goodwill
Goodwill
750000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Gross Profit
GrossProfit
980927
CY2019 us-gaap Gross Profit
GrossProfit
5716659
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
270000
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2179888
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1066644
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-430960
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
399000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
59415
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
79029
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
955500
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-335322
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
49052
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-208978
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
106267
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-100250
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
59129
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-49517
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3552
CY2020 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-476000
CY2019 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-31000
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
955500
CY2019 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17585
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10339
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-20113
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-271830
CY2020 us-gaap Interest Expense
InterestExpense
24025
CY2019 us-gaap Interest Expense
InterestExpense
7987
CY2020 us-gaap Interest Paid Net
InterestPaidNet
24025
CY2019Q4 us-gaap Liabilities
Liabilities
1681073
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4995010
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
34224
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
34224
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
44496
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
65040
CY2019 us-gaap Interest Paid Net
InterestPaidNet
7987
CY2020Q4 us-gaap Inventory Net
InventoryNet
163619
CY2019Q4 us-gaap Inventory Net
InventoryNet
181204
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
18109
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
27069
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
585264
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
342240
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
65040
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
165025
CY2020Q4 us-gaap Liabilities
Liabilities
1087278
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7257417
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
710345
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1281340
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-103049
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-277638
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4913
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87382
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1590447
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1123862
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-1748928
CY2019 us-gaap Net Income Loss
NetIncomeLoss
667644
CY2020Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
CY2019Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
188828
CY2020Q4 us-gaap Notes Payable
NotesPayable
304833
CY2019Q4 us-gaap Notes Payable
NotesPayable
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
304833
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
CY2019Q1 us-gaap Notes Receivable Net
NotesReceivableNet
276000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1491276
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
1047562
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
420239
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
460408
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43306
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
60675
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
376933
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
399733
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
445711
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
495377
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y
CY2020 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
205730
CY2019 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
CY2020Q4 us-gaap Other Assets
OtherAssets
1198223
CY2019Q4 us-gaap Other Assets
OtherAssets
1723889
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-688612
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19082
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
383909
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
126630
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4913
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
174590
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
257629
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
294644
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16196
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
304833
CY2019 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
CY2020 us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
CY2019 us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
87208
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4004717
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3999804
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
258856
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
323316
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.16
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
206966
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2020 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
112117
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16032364
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14272897
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3506268
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11567725
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
548070
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2472203
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4669097
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
74659
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
33997
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
6.36
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
9.1
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0036
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
9999
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6666
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13332
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13332
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.14
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.35
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
63327
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
53328
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
53328
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.594
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.391
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.384
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
29107
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.82
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.55
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.40
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.60
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.58
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
39996
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
53328
CY2020 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1
P5Y
CY2019 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1
P5Y
CY2020 us-gaap Stock Issued1
StockIssued1
CY2019 us-gaap Stock Issued1
StockIssued1
28202
CY2019 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5036
CY2020 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5119
CY2019 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
525
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7806
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3609
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3907732
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5576344
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5346501
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company's significant estimates include depreciation, amortization, impairment of goodwill and intangibles, stock-based compensation, allowance for doubtful accounts and deferred tax assets.</div></div></div></div></div></div></div>
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
484000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-8000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1024907
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1021865
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1024907
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1008979

Files In Submission

Name View Source Status
0001437749-21-007824-index-headers.html Edgar Link pending
0001437749-21-007824-index.html Edgar Link pending
0001437749-21-007824.txt Edgar Link pending
0001437749-21-007824-xbrl.zip Edgar Link pending
ex_237631.htm Edgar Link pending
ex_237632.htm Edgar Link pending
ex_237633.htm Edgar Link pending
ex_237634.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skas-20201231.xml Edgar Link completed
skas-20201231.xsd Edgar Link pending
skas-20201231_cal.xml Edgar Link unprocessable
skas-20201231_def.xml Edgar Link unprocessable
skas-20201231_lab.xml Edgar Link unprocessable
skas-20201231_pre.xml Edgar Link unprocessable
skas20201231_10k.htm Edgar Link pending